Observational Study
Copyright ©The Author(s) 2020.
World J Clin Cases. Dec 26, 2020; 8(24): 6306-6314
Published online Dec 26, 2020. doi: 10.12998/wjcc.v8.i24.6306
Table 2 Examination results of patients in different estimated glomerular filtration rate value groups
eGFR value [mL/(min·1.73 m2)]≥ 90, n = 2260-89, n = 4230-59, n = 5
Age in yr46.8 ± 11.458.3 ± 11.969.6 ± 16.101
Sex as M/F18/427/153/2
Antiviral treatment time in mo84.0 ± 30.9111.1 ± 39.296.8 ± 38.12
ALT in IU/L33.36 ± 16.8322.31 ± 10.3521.80 ± 10.32
Creatinine in µmol/L74.71 ± 9.9886.20 ± 12.83107.4 ± 12.543
BUN in mmol/L4.56 ± 1.175.38 ± 1.406.32 ± 1.494
Cases of increased BUN03 (7.1%)3 (60%)5
Blood phosphorus in mmol/L0.94 ± 0.161.01 ± 0.150.86 ± 0.206
Cases of decreased blood phosphorus4 (18.2%)7 (16.7%)2 (40%)
Cases of early renal injury8 (36.4%)20 (47.6%)3 (60%)
Cases of abnormal urine microalbumin3 (13.6%)4 (9.5%)1 (20%)
Cases of abnormal urine transferrin1 (4.5%)5 (11.9%)0
Cases of abnormal NAG enzyme5 (22.7%)8 (19.0%)1 (20%)
Cases of abnormal α1 microglobulin 5 (22.7%)11 (26.2%)3 (60%)
Cases of abnormal urine immunoglobulin 1 (4.5%)5 (11.9%)1 (20%)